Company / Operating Income
Emergent BioSolutions Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$100.1M
FY2025
5-year range
-$726.4M / $341.4M
FY2021-FY2025
Trend
+192.1%
vs FY2024
Sector context
#38 of 204
Health Care
What the data says
Emergent BioSolutions Inc.'s operating income of $100M is higher than 81% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$726M in FY2023 to $434M in FY2020.
Based on SEC 10-K filings.
$100M in FY2025 with a 5-year CAGR of -25.4%. Top quartile in the Health Care sector.
Improved from -$726M to $100M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -25.4%
- 10-Year CAGR
- -
Sector benchmark
-7.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -25.4%, indicating a declining trend.
- In FY2025, operating income increased 192.1% year-over-year.
- Ranks #38 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $100.1M | +192.1% |
| FY2024 | -$108.7M | +85.0% |
| FY2023 | -$726.4M | -327.3% |
| FY2022 | -$170.0M | -149.8% |
| FY2021 | $341.4M | -21.3% |
| FY2020 | $433.8M | +280.2% |
| FY2019 | $114.1M | +8.2% |
| FY2018 | $105.5M | -15.1% |
| FY2017 | $124.3M | +17.8% |
| FY2016 | $105.5M | -25.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026